<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Carbonic anhydrase IX (CAIX), a transmembrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>, seems to play a key role in the adaption of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells to <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>This study was designed to investigate the clinical role of CAIX and its association with Her-2 in a large cohort of adeno- (AC) and <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) of the esophagus and their <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Expression of CAIX and Her-2 was investigated immunohistochemically in formalin fixed, paraffin-embedded tissue from 330 esophageal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (182 ACS, 148 <z:mp ids='MP_0004207'>SCCs</z:mp>) </plain></SENT>
<SENT sid="3" pm="."><plain>Corresponding <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> in 137 cases, distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in 34 cases, and local recurrences in 14 cases were analyzed for CAIX expression </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 147 cases (44.5%) showed strong CAIX expression (AC: 46.7%; ACC: 41.9%) </plain></SENT>
<SENT sid="5" pm="."><plain>CAIX status of the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> influenced CAIX expression in corresponding <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> (P&lt;0.001, linear regression) </plain></SENT>
<SENT sid="6" pm="."><plain>High CAIX-expression was an independent prognostic factor for shorter overall and disease-free survival (Pâ‰¤0.05, Cox regression) </plain></SENT>
<SENT sid="7" pm="."><plain>Twenty-nine ACs (15.9%) and 6 <z:mp ids='MP_0004207'>SCCs</z:mp> (4.1%) showed Her-2 overexpression </plain></SENT>
<SENT sid="8" pm="."><plain>In AC, a significant positive correlation between the Her-2 status and CAIX expression was found (P=0.009, chi-square test) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: High CAIX expression is associated with shorter survival in <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, and the hypoxic phenotype seems to be preserved at least during formation of <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Inhibition of CAIX might reduce the ability of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells to establish disseminated disease </plain></SENT>
<SENT sid="11" pm="."><plain>In Her-2 overexpressing ACs, blocking of this tyrosine kinase, e.g., by monoclonal antibodies, might induce this effect </plain></SENT>
</text></document>